SCHEDULE 1Transitional, transitory and savings provisions
5
1
Where—
a
there is a decision referred to in paragraph 2; and
b
an application is submitted in accordance with the Biocidal Regulation for authorisation or mutual recognition in parallel of the COPR biocidal product on or before the date of approval of the active substance,
COPR shall cease to apply to the COPR biocidal product in accordance with sub-paragraphs (2) to (4).
2
Where a decision is taken to authorise the COPR biocidal product, COPR shall cease to apply to the biocidal product from the date of that decision.
3
Where the application referred to in sub-paragraph (1)(b) is rejected, COPR shall cease to apply to the COPR biocidal product at the expiry of—
a
180 days from the date of the decision to reject the application, in relation to the placing on the market of the biocidal product; and
b
365 days from the date of the decision to reject the application, in relation to the disposal and use of existing stocks of the biocidal product.
4
Where a decision is taken not to authorise the COPR biocidal product, COPR shall cease to apply to the COPR biocidal product at the expiry of—
a
180 days from the date of that decision in relation to the placing on the market of the biocidal product; and
b
365 days from the date of that decision in relation to the disposal and use of existing stocks of the biocidal product.